Literature DB >> 16088522

Line sepsis in the ICU: prevention, diagnosis, and management.

Dennis G Maki1, Christopher J Crnich.   

Abstract

Intravascular devices (IVDs) are universally employed in the intensive care unit. Although their use is essential for the administration of medications and IV fluids, they carry a substantial risk of infection, either from the device itself or from contamination of administered infusate. IVD-related infections lead to increased patient morbidity and mortality and excess costs, but they are preventable. The highest rates of IVD-related infection occur with central venous catheters (CVCs). Immunosuppression and other underlying illnesses further increase the risk of IVD-related infection. Coagulase-negative staphylococci, Staphylococcus aureus, and Candida spp. are the most frequent infecting organisms. The incidence of IVD-related infections may be minimized by simple measures, including maximal barrier precautions during CVC placement, specialized training for personnel placing IVDs, and use of chlorhexidine for cutaneous antisepsis. Management of line sepsis should include blood cultures, treatment with appropriate antibiotics or antifungals, and, in most cases, removal and culture of the IVD.

Entities:  

Year:  2003        PMID: 16088522     DOI: 10.1055/s-2003-37914

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  3 in total

1.  Incidence and risk factors of device-associated infections and associated mortality at the intensive care in the Dutch surveillance system.

Authors:  Tjallie I I van der Kooi; Annette S de Boer; Judith Manniën; Jan C Wille; Mariëlle T Beaumont; Ben W Mooi; Susan van den Hof
Journal:  Intensive Care Med       Date:  2006-12-05       Impact factor: 17.440

2.  Coagulase-negative Staphylococcus, catheter-related, bloodstream infections and their association with acute phase markers of inflammation in the intensive care unit: An observational study.

Authors:  Oleksa Rewa; John Muscedere; Steve Reynolds; Xuran Jiang; Daren K Heyland
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

3.  Cutaneous Microbiome Profiles Following Chlorhexidine Treatment in a 72-Hour Daily Follow-Up Paired Design: a Pilot Study.

Authors:  Jean-Luc C Mougeot; Micaela F Beckman; Farah Bahrani Mougeot; James M Horton
Journal:  Microbiol Spectr       Date:  2022-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.